News, Analysis & Insights on Nutrition, Supplements, and Health
Rock Creek Pharmaceuticals, formerly known as Star Scientific, has hit another pothole in the road in the form of a negative opinion from the Food and Drug Administration on its New Dietary Ingredient Notification (NDIN).
The US Federal Trade Commission’s motion against Bayer for claims made for its probiotic dietary supplement, Phillips’ Colon Health “warrants close monitoring” because of the potential wide-ranging implications, according to a prominent attorney.
German dairy cooperative Molkerei Ammerland has completed its first sweet whey powder (SWP) auction on the Global Dairy Trade (GDT) platform.
In today’s complex global marketplace, the patchwork of regulatory standards, cultural variations and logistical realities of time and space create an environment in which harmonisation may seem impossible. Not so, argues James C Griffiths, PhD, VP of...
Probiotic strain Lactobacillus paracasei could alter the intestinal microbial in healthy populations, but this depends strictly on the ‘ecosystem’ of the individual, according to research.
DSM Nutritional Products (DNP) wants to engage with commercial, government and academic entities at a 2-day open innovation (OI) summit with selected participants in December.
Nutricia Australia New Zealand’s (Nutricia ANZ) acquisition of Kiwi infant formula businesses the Sutton Group and Gardians is “key to restoring" consumer confidence lost as a result of the 2013 botulism scare.
South Korea
South Korea’s probiotic segment has been growing at around 30% over the last two years, and according to one international bioscience major, this lightning rate should continue for another year.
Omega Ingredients (OI) has doubled the size of its manufacturing facility and secured 16 new jobs by pumping £300,000 into its UK operations, ceo and founder Steve Pearce has said.
The sports and energy drink market has grown from £1bn in 2009 to £1.5bn in 2014 as tired consumers look to these products to beat fatigue, according to a report by Mintel.
The Designer Anabolic Steroid Control Act (DASCA) of 2014 (H.R. 4771) has passed the U.S. House of Representatives, a move praised by the Council for Responsible Nutrition (CRN).